Study characteristics for studies examining the relationship between PWV and mortality/morbidity outcomes
Study . | Sample size . | Age (years) . | Female (%) . | CKD Stage* . | DM (%) . | CVD (%) . | PWV (m/s) . | Outcome . | Comparison . | Effect estimate (95% CI) . | Follow-up duration (months) . |
---|---|---|---|---|---|---|---|---|---|---|---|
Dimkovic et al. [53] | 220 | 58.9 | 46 | Hemodialysis | 11.8 | 20 | 9.68 ± 2.12 | CV mortality |
|
| 76 |
Premuzic et al. [51] | 96 | 66 | 50 | Hemodialysis | NA | NA | 10.5 ± 1.9 | CV mortality |
|
| 25 |
Nemcsik et al. [50] | 100 | 66 | 52 | Non-hemodialysis | 44 | 64 |
|
|
|
| NA |
Townsend et al. [52] | 2795 | 59.9 | 43.6 | Non-hemodialysis | 47.3 | NA | NA | All-cause mortality |
|
| 65 |
Sarafidis et al. [43] | 170 | 63.8 | 69 | Hemodialysis | 54 | NA | 9.4 (2.2) |
|
|
| 28 |
Chiu et al. [44] | 219 | 64.2 | 32.3 | Hemodialysis | 39.4 | NA | 8.81 (2.08) |
|
|
| 28 |
He et al. [15] | 128 | 56 | 54 | Hemodialysis | 13.3 | NA | NR | All-cause mortality |
|
| 24 |
Baumann et al. [45] | 135 | 59.2 | 54 | Non-hemodialysis | 47 | NA | 10.5 (3.0) | All-cause mortality |
|
| 42 |
Avramovski et al. [46] | 80 | 59.3 | 34 | Hemodialysis | 20 | NA | 12.5 (2.01) |
|
|
| 36 |
Karras et al. [18] | 439 | 59.8 | 26 | Non-hemodialysis | 27 | 28 | 11.9 (3.4) |
|
|
| 56 |
Othmane et al. [47] | 98 | 63.4 | 39 | Hemodialysis | 40.8 | 60.2 | 11.2 (3.25) | CV mortality |
|
| 29 |
Zoungas et al. [25] | 207 | 57 | 32 | Non-hemodialysis | NA | 72 | NA |
|
|
| 60 |
Shoji et al. [48] | 256 | 55.4 | 59 | Hemodialysis | 19.5 | NA | 8.64 ± 2.16 |
|
|
| 63 |
Blacher et al. [49] | 241 | 51.5 | 39 | Hemodialysis | 7 | 24 | 11.1 ± 3.1 |
|
|
| 72 |
Study . | Sample size . | Age (years) . | Female (%) . | CKD Stage* . | DM (%) . | CVD (%) . | PWV (m/s) . | Outcome . | Comparison . | Effect estimate (95% CI) . | Follow-up duration (months) . |
---|---|---|---|---|---|---|---|---|---|---|---|
Dimkovic et al. [53] | 220 | 58.9 | 46 | Hemodialysis | 11.8 | 20 | 9.68 ± 2.12 | CV mortality |
|
| 76 |
Premuzic et al. [51] | 96 | 66 | 50 | Hemodialysis | NA | NA | 10.5 ± 1.9 | CV mortality |
|
| 25 |
Nemcsik et al. [50] | 100 | 66 | 52 | Non-hemodialysis | 44 | 64 |
|
|
|
| NA |
Townsend et al. [52] | 2795 | 59.9 | 43.6 | Non-hemodialysis | 47.3 | NA | NA | All-cause mortality |
|
| 65 |
Sarafidis et al. [43] | 170 | 63.8 | 69 | Hemodialysis | 54 | NA | 9.4 (2.2) |
|
|
| 28 |
Chiu et al. [44] | 219 | 64.2 | 32.3 | Hemodialysis | 39.4 | NA | 8.81 (2.08) |
|
|
| 28 |
He et al. [15] | 128 | 56 | 54 | Hemodialysis | 13.3 | NA | NR | All-cause mortality |
|
| 24 |
Baumann et al. [45] | 135 | 59.2 | 54 | Non-hemodialysis | 47 | NA | 10.5 (3.0) | All-cause mortality |
|
| 42 |
Avramovski et al. [46] | 80 | 59.3 | 34 | Hemodialysis | 20 | NA | 12.5 (2.01) |
|
|
| 36 |
Karras et al. [18] | 439 | 59.8 | 26 | Non-hemodialysis | 27 | 28 | 11.9 (3.4) |
|
|
| 56 |
Othmane et al. [47] | 98 | 63.4 | 39 | Hemodialysis | 40.8 | 60.2 | 11.2 (3.25) | CV mortality |
|
| 29 |
Zoungas et al. [25] | 207 | 57 | 32 | Non-hemodialysis | NA | 72 | NA |
|
|
| 60 |
Shoji et al. [48] | 256 | 55.4 | 59 | Hemodialysis | 19.5 | NA | 8.64 ± 2.16 |
|
|
| 63 |
Blacher et al. [49] | 241 | 51.5 | 39 | Hemodialysis | 7 | 24 | 11.1 ± 3.1 |
|
|
| 72 |
DM, diabetes mellitus; OR, odds ratio.
Study characteristics for studies examining the relationship between PWV and mortality/morbidity outcomes
Study . | Sample size . | Age (years) . | Female (%) . | CKD Stage* . | DM (%) . | CVD (%) . | PWV (m/s) . | Outcome . | Comparison . | Effect estimate (95% CI) . | Follow-up duration (months) . |
---|---|---|---|---|---|---|---|---|---|---|---|
Dimkovic et al. [53] | 220 | 58.9 | 46 | Hemodialysis | 11.8 | 20 | 9.68 ± 2.12 | CV mortality |
|
| 76 |
Premuzic et al. [51] | 96 | 66 | 50 | Hemodialysis | NA | NA | 10.5 ± 1.9 | CV mortality |
|
| 25 |
Nemcsik et al. [50] | 100 | 66 | 52 | Non-hemodialysis | 44 | 64 |
|
|
|
| NA |
Townsend et al. [52] | 2795 | 59.9 | 43.6 | Non-hemodialysis | 47.3 | NA | NA | All-cause mortality |
|
| 65 |
Sarafidis et al. [43] | 170 | 63.8 | 69 | Hemodialysis | 54 | NA | 9.4 (2.2) |
|
|
| 28 |
Chiu et al. [44] | 219 | 64.2 | 32.3 | Hemodialysis | 39.4 | NA | 8.81 (2.08) |
|
|
| 28 |
He et al. [15] | 128 | 56 | 54 | Hemodialysis | 13.3 | NA | NR | All-cause mortality |
|
| 24 |
Baumann et al. [45] | 135 | 59.2 | 54 | Non-hemodialysis | 47 | NA | 10.5 (3.0) | All-cause mortality |
|
| 42 |
Avramovski et al. [46] | 80 | 59.3 | 34 | Hemodialysis | 20 | NA | 12.5 (2.01) |
|
|
| 36 |
Karras et al. [18] | 439 | 59.8 | 26 | Non-hemodialysis | 27 | 28 | 11.9 (3.4) |
|
|
| 56 |
Othmane et al. [47] | 98 | 63.4 | 39 | Hemodialysis | 40.8 | 60.2 | 11.2 (3.25) | CV mortality |
|
| 29 |
Zoungas et al. [25] | 207 | 57 | 32 | Non-hemodialysis | NA | 72 | NA |
|
|
| 60 |
Shoji et al. [48] | 256 | 55.4 | 59 | Hemodialysis | 19.5 | NA | 8.64 ± 2.16 |
|
|
| 63 |
Blacher et al. [49] | 241 | 51.5 | 39 | Hemodialysis | 7 | 24 | 11.1 ± 3.1 |
|
|
| 72 |
Study . | Sample size . | Age (years) . | Female (%) . | CKD Stage* . | DM (%) . | CVD (%) . | PWV (m/s) . | Outcome . | Comparison . | Effect estimate (95% CI) . | Follow-up duration (months) . |
---|---|---|---|---|---|---|---|---|---|---|---|
Dimkovic et al. [53] | 220 | 58.9 | 46 | Hemodialysis | 11.8 | 20 | 9.68 ± 2.12 | CV mortality |
|
| 76 |
Premuzic et al. [51] | 96 | 66 | 50 | Hemodialysis | NA | NA | 10.5 ± 1.9 | CV mortality |
|
| 25 |
Nemcsik et al. [50] | 100 | 66 | 52 | Non-hemodialysis | 44 | 64 |
|
|
|
| NA |
Townsend et al. [52] | 2795 | 59.9 | 43.6 | Non-hemodialysis | 47.3 | NA | NA | All-cause mortality |
|
| 65 |
Sarafidis et al. [43] | 170 | 63.8 | 69 | Hemodialysis | 54 | NA | 9.4 (2.2) |
|
|
| 28 |
Chiu et al. [44] | 219 | 64.2 | 32.3 | Hemodialysis | 39.4 | NA | 8.81 (2.08) |
|
|
| 28 |
He et al. [15] | 128 | 56 | 54 | Hemodialysis | 13.3 | NA | NR | All-cause mortality |
|
| 24 |
Baumann et al. [45] | 135 | 59.2 | 54 | Non-hemodialysis | 47 | NA | 10.5 (3.0) | All-cause mortality |
|
| 42 |
Avramovski et al. [46] | 80 | 59.3 | 34 | Hemodialysis | 20 | NA | 12.5 (2.01) |
|
|
| 36 |
Karras et al. [18] | 439 | 59.8 | 26 | Non-hemodialysis | 27 | 28 | 11.9 (3.4) |
|
|
| 56 |
Othmane et al. [47] | 98 | 63.4 | 39 | Hemodialysis | 40.8 | 60.2 | 11.2 (3.25) | CV mortality |
|
| 29 |
Zoungas et al. [25] | 207 | 57 | 32 | Non-hemodialysis | NA | 72 | NA |
|
|
| 60 |
Shoji et al. [48] | 256 | 55.4 | 59 | Hemodialysis | 19.5 | NA | 8.64 ± 2.16 |
|
|
| 63 |
Blacher et al. [49] | 241 | 51.5 | 39 | Hemodialysis | 7 | 24 | 11.1 ± 3.1 |
|
|
| 72 |
DM, diabetes mellitus; OR, odds ratio.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.